{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:42:05Z","timestamp":1788576125290,"version":"build-2803163510"},"reference-count":22,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,8]]},"abstract":"<jats:p>Liposomal amphotericin B is being used increasingly to reduce the burden of kala-azar from the Indian subcontinent. There are studies which have evaluated efficacy and safety of liposomal amphotericin B for visceral leishmaniasis in all age groups. However, the only study that specifically addressed treatment of childhood visceral leishmaniasis did not include all ages or document renal and liver function. We, therefore, felt it was important to reassess the efficacy and safety of single dose liposomal amphotericin B in children and adolescents. A total of 100 parasitologically confirmed visceral leishmaniasis patients aged &lt; 15 years were included in this study. Participants consisted of 65 males and 35 females. All of them had come from the endemic region of Bihar. They were administered one dose intravenous infusion of liposomal amphptericin B at 10 mg\/kg body weight. Efficacy was assessed as initial and final cure at 1 and 6 months, respectively, and safety of all participants who were recruited in the study. The initial and final cure rate by per protocol analysis was 100% and 97.9%, respectively. Chills and rigors were the most commonly occurring adverse events (AEs). All the AEs were mild in intensity, and none of the patients experienced any serious AEs. No patients developed nephrotoxicity. Our finding indicates that liposomal amphotericin B at 10 mg\/kg body weight is safe and effective in children. Results of our study support the use of single dose liposomal amphotericin B in all age group populations for elimination of kala-azar from the Indian subcontinent.<\/jats:p>","DOI":"10.4269\/ajtmh.17-0094","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T07:00:30Z","timestamp":1504681230000},"page":"1498-1502","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India"],"prefix":"10.4269","volume":"97","author":[{"given":"Krishna","family":"Pandey","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (Indian, Council of Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyamat Ali","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Rajendra Memorial Research Institute of Medical Sciences (Indian Council, of Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Nand","family":"Rabi Das","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (Indian, Council of Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Murti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Shekhar","family":"Lal","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, (Indian Council of Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rajendra Memorial Research Institute of Medical Sciences (Indian Council of, Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Babu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahab","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, (Indian Council of Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences (Indian, Council of Medical Research), Patna, Bihar, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences (Indian, Council of Medical Research), Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"PLoS One","first-page":"e35671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012"},{"key":"b2","series-title":"Indian J Med Res","first-page":"345","article-title":"Visceral leishmaniasis\u2014current therapeutic modalities","volume":"123","author":"Sundar","year":"2006"},{"key":"b3","series-title":"Lancet Infect Dis","first-page":"87","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003"},{"key":"b4","series-title":"Indian J Med Res","first-page":"166","article-title":"Epidemiological, clinical and pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India","volume":"120","author":"Thakur","year":"2004"},{"key":"b5","series-title":"Clin Infect Dis","first-page":"543","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012"},{"key":"b6","series-title":"PLoS Negl Trop Dis","first-page":"e0004118","article-title":"Effectiveness study of paromomycin IM injection (PMIM) for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"9","author":"Jamil","year":"2015"},{"key":"b7","series-title":"Clin Infect Dis","first-page":"377","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004"},{"key":"b8","series-title":"N Engl J Med","first-page":"504","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010"},{"key":"b9","series-title":"Lancet Glob Health","first-page":"e51","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"Mondal","year":"2014"},{"key":"b10","year":"2006"},{"key":"b11"},{"key":"b12","series-title":"Clin Infect Dis","first-page":"560","article-title":"Two doses of a lipid formulation of amphotericin B for the treatment of mediterranean visceral leishmaniasis","volume":"36","author":"Syriopoulou","year":"2003"},{"key":"b13","series-title":"Clin Infect Dis","first-page":"1000","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"Sundar","year":"2008"},{"key":"b14","series-title":"Lancet","first-page":"477","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"Sundar","year":"2011"},{"key":"b15","series-title":"Trans R Soc Trop Med Hyg","first-page":"432","article-title":"Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study","volume":"94","author":"Thakur","year":"2000"},{"key":"b16","series-title":"J Antimicrob Chemother","first-page":"229","article-title":"Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature","volume":"55","author":"Pagliano","year":"2005"},{"key":"b17","series-title":"PLoS Negl Trop Dis","first-page":"e3169","article-title":"Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, Open-Label Study","volume":"8","author":"Sundar","year":"2014"},{"key":"b18","series-title":"Clin Infect Dis","first-page":"800","article-title":"R Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study","volume":"37","author":"Sundar","year":"2003"},{"key":"b19","series-title":"Am J Trop Med Hyg","first-page":"357","article-title":"Effectiveness and safety of liposomal amphotericin b for visceral leishmaniasis under routine program conditions in Bihar, India","volume":"83","author":"Sinha","year":"2010"},{"key":"b20","series-title":"Int J Antimicrob Agents","first-page":"67","article-title":"A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study","volume":"17","author":"Thakur","year":"2001"},{"key":"b21","series-title":"BMJ","first-page":"419","article-title":"Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial","volume":"323","author":"Sundar","year":"2001"},{"key":"b22","series-title":"Am J Trop Med Hyg","first-page":"143","article-title":"Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study","volume":"66","author":"Sundar","year":"2002"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/97\/5\/article-p1498.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/97\/5\/article-p1498.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/97\/5\/article-p1498.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T22:50:16Z","timestamp":1722466216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/97\/5\/article-p1498.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":22,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.17-0094","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}